These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 19844987)

  • 21. Acute myocardial infarction in sickle cell anemia.
    Martin CR; Cobb C; Tatter D; Johnson C; Haywood LJ
    Arch Intern Med; 1983 Apr; 143(4):830-1. PubMed ID: 6838304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mathematical modeling and computer simulation of erythrocytapheresis for SCD.
    Nifong TP; Bongiovanni MB; Gerhard GS
    Transfusion; 2001 Feb; 41(2):256-63. PubMed ID: 11239232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From total blood exchange to erythrocytapheresis and back to treat complications of sickle cell disease.
    Ballas SK
    Transfusion; 2017 Sep; 57(9):2277-2280. PubMed ID: 28470719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic cytapheresis.
    Klein HG
    Prog Clin Biol Res; 1982; 106():297-306. PubMed ID: 6757946
    [No Abstract]   [Full Text] [Related]  

  • 25. Transfusion medicine illustrated. Sickle cell disease: splenectomy and thrombocytosis.
    Anwar F; Abdelaal M; Albaiti A; Felimban S
    Transfusion; 2008 Jan; 48(1):10-1. PubMed ID: 18184234
    [No Abstract]   [Full Text] [Related]  

  • 26. Endotoxic shock after transfusion of contaminated red blood cells in a child with sickle cell disease.
    Foreman NK; Wang WC; Cullen EJ; Stidham GL; Pearson TA; Shenep JL
    Pediatr Infect Dis J; 1991 Aug; 10(8):624-6. PubMed ID: 1909782
    [No Abstract]   [Full Text] [Related]  

  • 27. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts.
    King AA; Noetzel M; White DA; McKinstry RC; Debaun MR
    Pediatr Blood Cancer; 2008 Mar; 50(3):599-602. PubMed ID: 17985350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tropical malaria and sickle-cell anemia: a tropical surprise].
    Boringa JB; de Jong GM
    Tijdschr Kindergeneeskd; 1992 Aug; 60(4):120-2. PubMed ID: 1440554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute splenic sequestration crisis in adults with sickle cell anemia.
    Koduri PR
    Am J Hematol; 2007 Feb; 82(2):174-5. PubMed ID: 16924644
    [No Abstract]   [Full Text] [Related]  

  • 30. Continuous RBC transfusions in a patient with sickle cell disease.
    Finch CA; Lee MY; Leonard JM
    Arch Intern Med; 1982 Feb; 142(2):279-82. PubMed ID: 7059256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transfusion therapy in sickle cell disease.
    Gibbons PT
    Nurs Clin North Am; 1983 Mar; 18(1):201-5. PubMed ID: 6550863
    [No Abstract]   [Full Text] [Related]  

  • 32. Rituximab for prevention of delayed hemolytic transfusion reaction in sickle cell disease.
    Noizat-Pirenne F; Bachir D; Chadebech P; Michel M; Plonquet A; Lecron JC; Galactéros F; Bierling P
    Haematologica; 2007 Dec; 92(12):e132-5. PubMed ID: 18055978
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myocardial injury or infarction associated with fat embolism in sickle cell disease: a report of three cases with survival.
    Dang NC; Johnson C; Eslami-Farsani M; Haywood LJ
    Am J Hematol; 2005 Oct; 80(2):133-6. PubMed ID: 16184576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
    Liem RI; O'Gorman MR; Brown DL
    Am J Hematol; 2004 May; 76(1):19-25. PubMed ID: 15114592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical effects of different types of red cell concentrates in patients with thalassemia and sickle cell disease.
    Cabibbo S; Fidone C; Antolino A; Manenti OG; Garozzo G; Travali S; Bennardello F; Di Stefano R; Bonomo P
    Transfus Clin Biol; 2007 Dec; 14(6):542-50. PubMed ID: 18434227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma exchange in critically ill patients with sickle cell disease.
    Boga C; Kozanoglu I; Ozdogu H; Ozyurek E
    Transfus Apher Sci; 2007 Aug; 37(1):17-22. PubMed ID: 17707694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sickle-cell anaemia with complicating coronary infarction.
    Woodruff AW
    Proc R Soc Med; 1970 Dec; 63(12):1314. PubMed ID: 5490798
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of erythrocytapheresis on natural anticoagulant levels in children with sickle cell disease: A pilot study.
    Sharma R; Woods GM; Creary S; O'Brien S; Stanek J; Hor K; Gallagher C; Dunn AL; Kumar R
    Pediatr Blood Cancer; 2019 Apr; 66(4):e27588. PubMed ID: 30548773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic red blood cell exchange to prevent clinical complications in sickle cell disease.
    Cabibbo S; Fidone C; Garozzo G; Antolino A; Manenti GO; Bennardello F; Licitra V; Calabrese S; Costantino F; Travali S; Distefano R; Bonomo P
    Transfus Apher Sci; 2005 Jun; 32(3):315-21. PubMed ID: 15908276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial infarction in sickle-cell disease.
    Pavlů J; Ahmed RE; O'Regan DP; Partridge J; Lefroy DC; Layton DM
    Lancet; 2007 Jan; 369(9557):246. PubMed ID: 17240292
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.